Pirtobrutinib
New Drug Approvals
MAY 8, 2025
Pirtobrutinib CAS 2101700-15-4 JAYPIRCA RXC-005 LY3527727 LOXO-305 WHO 11681 WeightAverage: 479.436 Monoisotopic: 479.158052208 Chemical FormulaC 22 H 21 F 4 N 5 O 3 5-amino-3-[4-[[(5-fluoro-2-methoxybenzoyl)amino]methyl]phenyl]-1-[(2 S )-1,1,1-trifluoropropan-2-yl]pyrazole-4-carboxamide FDA 2023, 1/27/2023, Jaypirca To treat relapsed or refractory mantle cell lymphoma in adults who have had at least two lines of systemic therapy, including a BTK inhibitor Drug Trials Snapshot Pirtobrutinib , so
Let's personalize your content